Zurich Cantonal Bank
BEAT

Zurich Cantonal Bank’s BioTelemetry, Inc. BEAT Stock Holding History

Zurich Cantonal Bank’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,868
Closed -$351K – 2695
2020
Q4 		$351K Hold
4,868
– – ﹤0.01% 1488
2020
Q3 		$222K Hold
4,868
– – ﹤0.01% 1519
2020
Q2 		$220K Buy
4,868
+1,930
+66% +$86.5K ﹤0.01% 1461
2020
Q1 		$113K Buy
2,938
+954
+48% +$43.9K ﹤0.01% 1548
2019
Q4 		$92K Hold
1,984
– – ﹤0.01% 1771
2019
Q3 		$81K Hold
1,984
– – ﹤0.01% 1733
2019
Q2 		$96K Sell
1,984
-87
-4% -$4.57K ﹤0.01% 1643
2019
Q1 		$130K Sell
2,071
-815
-28% -$56K ﹤0.01% 1424
2018
Q4 		$172K Hold
2,886
– – ﹤0.01% 1284
2018
Q3 		$186K Hold
2,886
– – ﹤0.01% 1347
2018
Q2 		$130K Hold
2,886
– – ﹤0.01% 1512
2018
Q1 		$90K Buy
2,886
+223
+8% +$7.33K ﹤0.01% 1660
2017
Q4 		$80K Buy
2,663
+816
+44% +$23.6K ﹤0.01% 1723
2017
Q3 		$61K Hold
1,847
– – ﹤0.01% 1681
2017
Q2 		$62K Buy
1,847
+301
+19% +$8.98K ﹤0.01% 1641
2017
Q1 		$45K Buy
+1,546
New +$38.3K ﹤0.01% 1809

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Zurich Cantonal Bank's BEAT Position: Q1 2021 in Review

Zurich Cantonal Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 4,868 shares — an estimated $351K sold.

Zurich Cantonal Bank first reported a position in BEAT in Q1 2017 and held it in 16 quarters. The position peaked at $351K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Zurich Cantonal Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 4,868 BioTelemetry, Inc. shares in Q1 2021, an estimated $351K.
  • Zurich Cantonal Bank first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 16 quarters.
  • Zurich Cantonal Bank's BioTelemetry, Inc. position peaked at $351K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Zurich Cantonal Bank's 13F filing for Q1 2021, filed 3 May 2021.